Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000

2016 ◽  
Vol 94 (1) ◽  
pp. 100-111 ◽  
Author(s):  
Prashant R. Tembhare ◽  
Sitaram Ghogale ◽  
Nisha Ghatwai ◽  
Yajamanam Badrinath ◽  
Nikesh Kunder ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Lymphoblastic Leukemia ◽  
Disease Monitoring ◽  
Cell Precursor ◽  
Minimal Residual Disease Monitoring ◽  
Minimal Residual

scholarly journals Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia

2020 ◽  
Vol 61 (11) ◽  
pp. 2665-2673 ◽  
Author(s):  
Nicola Gökbuget ◽  
Gerhard Zugmaier ◽  
Hervé Dombret ◽  
Anthony Stein ◽  
Massimiliano Bonifacio ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Lymphoblastic Leukemia ◽  
Cell Precursor ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document